Terry-Ann Burrell - 30 Jun 2021 Form 4 Insider Report for Beam Therapeutics Inc. (BEAM)

Role
CFO
Signature
/s/ Christine Bellon, Attorney-in-fact
Issuer symbol
BEAM
Transactions as of
30 Jun 2021
Net transactions value
-$3,249,600
Form type
4
Filing time
02 Jul 2021, 18:01:02 UTC
Previous filing
30 Jun 2021
Next filing
06 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BEAM Common Stock Options Exercise $410,400 +30,000 +121% $13.68 54,809 30 Jun 2021 Direct F1
transaction BEAM Common Stock Sale $1,755,000 -15,000 -27% $117.00 39,809 30 Jun 2021 Direct F2
transaction BEAM Common Stock Sale $1,905,000 -15,000 -38% $127.00 24,809 30 Jun 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BEAM Stock Option (Right to Buy) Options Exercise $0 -30,000 -9.6% $0.000000 282,941 30 Jun 2021 Common Stock 30,000 $13.68 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option exercise reported in this Form 4 was effected pursuant to a 10b5-1 trading plan.
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F3 The option vests as to 25% on the first anniversary of the of the vesting commencement date, August 20, 2019, and at a rate of 2.78% each month thereafter until the option is fully vested.